Home
Conditions
Neuroectodermal Tumors, Primitive

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

727 public trials 122 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Completed

Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer

NCT00509665

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cranial Nerve Diseases, +22 more
Locations: Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

NCT00923351

Conditions: Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +20 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors

NCT00931931

Conditions: Clival Chordoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing Sarcoma, +46 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Completed

Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study

NCT01737671

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumor, +19 more
Locations: Children's Memorial Hermann Hospital Houston, Texas, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas

NCT02130869

Conditions: Hemic and Lymphatic Diseases, High-risk Tumor, Immune System Diseases, +14 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

NCT01171469

Conditions: Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +19 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

NCT00381797

Conditions: Central Nervous System Diseases, Central Nervous System Neoplasms, Childhood Cerebral Anaplastic Astrocytoma, +22 more
Locations: UCSF Medical Center-Mount Zion San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Lurie Children's Hospital-Chicago Chicago, Illinois, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

NCT01825902

Conditions: Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, +12 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

NCT00405327

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +25 more
Locations: University of Michigan, Department of Surgery, Pediatric Section Ann Arbor, Michigan, United States

View Trial Details

Completed

N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma

NCT00659984

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Childrens Hospital Los Angeles Los Angeles, California, United States

Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

University of Chicago Comer Children's Hospital Chicago, Illinois, United States

View Trial Details

Neuroectodermal Tumors, Primitive

Neuroectodermal Tumors, Primitive trial results

Related conditions